02/11/2022
CLECELL signed a joint business MoU to promote the commercialization of an anti-cancer drug sensitivity test with CancerFree Biotech 3D bioprinting company CLECELL announced that it had signed an MoU with Taiwanese bio company CancerFree Biotech for the commercialization of an organoid-based anti-ca...